Kit and FcεRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells

Blood

Volumn 104, Issue 8, 2004, Pages 2410-2417

  Hundley, Thomas R ^a   Gilfillan, Alasdair M ^a   Tkaczyk, Christine ^a   Andrade, Marcus V ^a   Metcalfe, Dean D ^a   Beaven, Michael A ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD34 ANTIGEN; CYTOKINE; FC EPSILON RECEPTOR 1; FC RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA; PROTEIN KINASE B; PROTEIN KINASE C; STAT5 PROTEIN; STAT6 PROTEIN; STEM CELL FACTOR; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; AKT1 PROTEIN, HUMAN; AUTACOID; CALCIUM; DNA BINDING PROTEIN; IMMUNOGLOBULIN E RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE; MILK PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE; STAT6 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; MAST CELL; MAST CELL DEGRANULATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; CALCIUM SIGNALING; CELL CULTURE; DEGRANULATION; GENETICS; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; SECRETION;

CALCIUM; CALCIUM SIGNALING; CELL DEGRANULATION; CELLS, CULTURED; CYTOKINES; DNA-BINDING PROTEINS; HUMANS; INFLAMMATION MEDIATORS; INOSITOL 1,4,5-TRISPHOSPHATE; MAST CELLS; MILK PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, IGE; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; STAT6 TRANSCRIPTION FACTOR; STEM CELL FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 4944228934     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-02-0631     Document Type: Article

References (67)

1. Gordon JR. FcεRI-induced cytokine production and gene expression. In: Hamawy MM, ed. IgE Receptor (FceRI) Function in Mast Cells and Basophils. Austin, TX: R. G. Landes Company; 1997:209-242.
2. Galli SJ, Zsebo KM, Geissler EN. The kit ligand, stem cell factor. Adv Immunol. 1994;55:1-96.
3. Taylor ML, Metcalfe DD. Kit signal transduction. Hematol Oncol Clin North Am. 2000;14:517-535.
4. Valent P. The riddle of the mast cell: kit(CD117)-ligand as the missing link? Immunol Today. 1994;15:111-114.
5. Bischoff SC, Dahinden CA. c-kit ligand: a unique potentiator of mediator release by human lung mast cells. J Exp Med. 1992;175:237-244.
6. Lorentz A, Schwengberg S, Sellge G, Manns MP, Bischoff SC. Human intestinal mast cells are capable of producing different cytokine profiles: role of IgE receptor cross-linking and IL-4. J Immunol. 2000;164:43-48.
7. Gagari E, Tsai M, Lantz CS, Fox LG, Galli SJ. Differential release of mast cell interleukin-6 via c-kit. Blood. 1997;89:2654-2663.
8. Ishizuka T, Kawasome H, Terada N, et al. Stem cell factor augments FcεRI-mediated TNF-α production and stimulates MAP kinases via a different pathway in MC/9 mast cells. J Immunol. 1998;161:3624-3630.
9. Okayama Y, Kobayashi H, Ashman LK, et al. Human lung mast cells are enriched in the capacity to produce granulocyte-macrophage colony-stimulating factor in response to IgE-dependent stimulation. Eur J Immunol. 1998;28:708-715.
10. Columbo M, Horowitz EM, Botana LM, et al. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol. 1992;149:599-608.
11. Coleman JW, Holliday MR, Kimber I, Zsebo KM, Galli SJ. Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 or IL-4. J Immunol. 1993;150:556-562.
12. Takaishi T, Morita Y, Hirai K, et al. Effect of cytokines on mediator release from human dispersed lung mast cells. Allergy. 1994;49:837-842.
13. Gibbs BF, Arm JP, Gibson K, Lee TH, Pearce FL. Human lung mast cells release small amounts of interleukin-4 and tumour necrosis factor-α in response to stimulation by anti-IgE and stem cell factor. Eur J Pharmacol. 1997;327:73-78.
14. Taylor AM, Galli SJ, Coleman JW. Stem-cell factor, the kit ligand, induces direct degranulation of rat peritoneal mast cells in vitro and in vivo: dependence of the in vitro effect on period of culture and comparisons of stem-cell factor with other mast cell-activating agents. Immunology. 1995;86:427-433.
15. Garrington TP, Ishizuka T, Papst PJ, et al. MEKK2 gene disruption causes loss of cytokine production in response to IgE and c-Kit ligand stimulation of ES cell-derived mast cells. EMBO J. 2000;19:5387-5395.
16. Ishizuka T, Chayama K, Takeda K, et al. Mitogen-activated protein kinase activation through FcεRI and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells. J Immunol. 1999;162:2087-2094.
17. Okayama Y, Hagamann DD, Metcalfe DD. A comparison of mediators released or generated by IFN-γ-treated human mast cells following aggregation of FcγRI or FcεRI. J Immunol. 2001;166:4705-4712.
18. Wakahara S, Fujii Y, Nakao T, et al. Gene expression profiles for FcεRI, cytokines and chemokines upon FcεRI activation in human cultured mast cells derived from peripheral blood. Cytokine. 2001;16:143-152.
19. Hamawy MM, Mergenhagen SE, Siraganian RP. Protein tyrosine phosphorylation as a mechanism of signalling in mast cells and basophils. Cell Signalling. 1995;7:535-544.
20. Linnekin D. Early signaling pathways activated by c-Kit in hematopoietic cells. Int J Biochem Cell Biol. 1999;31:1053-1074.
21. Koike T, Hirai K, Morita Y, Nozawa Y. Stem cell factor-induced signal transduction in rat mast cells: activation of phospholipase D but not phosphoinositide-specific phospholipase C in c-kit receptor stimulation. J Immunol. 1993;151:359-366.
22. Turner H, Kinet JP. Signalling through the high-affinity IgE receptor FcεRI. Nature. 1999;402: B24-B29.
23. Rivera J. Molecular adapters in FcεRI signaling and the allergic response. Curr Opin Immunol. 2002;14:688-693.
24. Beaven MA, Metzger H. Signal transduction by Fc receptors: the Fcε case. Immunol Today. 1993;14:222-226.
25. 2+ levels in human adult skin mast cells activated by the ligand for the human c-kit receptor and anti-IgE. Biochem Pharmacol. 1994;47:2137-2145.
26. Malaviya R, Uckun FM. Role of STAT6 in IgE receptor/FcεRI-mediated late phase allergic responses of mast cells. J Immunol. 2002;168:421-426.
27. +, and expresses aminopeptidase N (CD13). Blood. 1999;94:2333-2342.
28. + cells: comparisons with tumor mast cell lines. J Immunol. 2001;166:6647-6656.
29. Okayama Y, Tkaczyk C, Metcalfe DD, Gilfillan AM. Comparison of FcεRI- and Fc-γRI-mediated degranulation and TNF-α synthesis in human mast cells: selective utilization of phosphatidylinositol-3-kinase for FcγRI-induced degranulation. Eur J Immunol. 2003;33:1450-1459.
30. Gupta S, Barrett T, Whitmarsh AJ, et al. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 1996;15:2760-2770.
31. Raingeaud J, Gupta S, Rogers JS, et al. Pro-inflammatory cytokines and environmental stress cause p38-mitogen protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem. 1995;270:7420-7426.
32. Derijard B, Hibi M, Wu IH, et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 1994;76:1025-1037.
33. Kyriakis JM, Banerjee P, Nikolakaki E, et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature. 1994;369:156-160.
34. van Dam H, Wilhelm D, Herr I, et al. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J. 1995;14:1798-1811.
35. Gouilleux F, Wakao H, Mundt M, Groner B. Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J. 1994;13:4361-4369.
36. Quelle FW, Shimoda K, Thierfelder W, et al. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol Cell Biol. 1995;15:3336-3343.
37. Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene. 2002;285:1-24.
38. Schmitz ML, Bacher S, Kracht M. Iκ B-independent control of NF-κB activity by modulatory phosphorylations. Trends Biochem Sci. 2001;26:186-190.
39. 2+ and purified isozymes in washed permeabilized cells. J Biol Chem. 1993;268:1749-1756.
40. 1 pathway of FcεRI-mediated mast cell activation is regulated independently of phosphatidylinositol 3-kinase. J Biol Chem. 2003;278:48474-48484.
41. Beaven MA, Ozawa K. Role of calcium, protein kinase C, and MAP kinase in the activation of mast cells. Allergol Internat. 1996;45:73-84.
42. Parker PJ, Parkinson SJ. AGC protein kinase phosphorylation and protein kinase C. Biochem Soc Trans. 2001;29:860-863.
43. Newton AC. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem J. 2003;370:361-371.
44. Billah MM, Anthes JC. The regulation and cellular function of phosphatidylcholine hydrolysis. Biochem J. 1990;269:281-291.
45. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 1995;9:484-496.
46. Wakelam MJO. Diacylglycerol-when is it an intracellular messenger? Biochim Biophys Acta. 1998;1436:117-126.
47. Chayama K, Papst PJ, Garrington TP, et al. Role of MEKK2-MEK5 in the regulation of TNF-alpha gene expression and MEKK2-MKK7 in the activation of c-Jun N-terminal kinase in mast cells. Proc Natl Acad Sci U S A. 2001;98:4599-4604.
48. Hirasawa N, Sato Y, Fujita Y, Ohuchi K. Involvement of a phosphatidylinositol 3-kinase-p38 mitogen activated proteiin kinase pathway in antigen-induced IL-4 production in mast cells. Biochim Biophys Acta. 2000;1456:45-55.
49. Kalesnikoff J, Baur N, Leitges M, et al. SHIP negatively regulates IgE + antigen-induced IL-6 production in mast cells by inhibiting NF-kappa B activity. J Immunol. 2002;168:4737-4746.
50. Zhang C, Baumgartner RA, Yamada K, Beaven MA. Mitogen activated protein (MAP) kinase regulates production of TNFα and release of arachidonic acid in mast cells: Indications of communication between p38 and p42 MAP kinases. J Biol Chem. 1997;272:13397-13402.
51. Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer. 2002;2:489-501.
52. Lorentz A, Klopp I, Gebhardt T, Manns MP, Bischoff SC. Role of activator protein 1, nuclear factor-κB, and nuclear factor of activated T cells in IgE receptor-mediated cytokine expression in mature human mast cells. J Allergy Clin Immunol. 2003;111:1062-1068.
53. Peron P, Rahmani M, Zagar Y et al. Potentiation of Smad transactivation by Jun proteins during a combined treatment with epidermal growth factor and transforming growth factor- β in rat hepatocytes: role of phosphatidylinositol 3-kinase-induced AP-1 activation. J Biol Chem. 2001;276:10524-10531.
54. Razin E, Szallasi Z, Kazanietz MG, Blumberg PM, Rivera J. Protein kinase C-β and C-ε link the mast cell high-affinity receptor for IgE to the expression of c-fos and c-jun. Proc Natl Acad Sci U S A. 1994;91:7722-7726.
55. Pearson G, Robinson F, Beers GT, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001;22:153-183.
56. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol. 2002;4:E131-E136.
57. Pelletier C, Varine-Blank N, Rivera J, et al. FcεRI-mediated induction of TNF-α gene expression in the RBL-2H3 mast cell line: regulation by a novel NF-κB-like nuclear binding complex. J Immunol. 1998;161:4768-4776.
58. Marquardt DL, Walker LL. Dependence of mast cell IgE-mediated cytokine production on nuclear factor-κB activity. J Allergy Clin Immunol. 2000;105:500-505.
59. Coward WR, Okayama Y, Sagara H, et al. NF-κB and TNF-α: a positive autocrine loop in human lung mast cells? J Immunol. 2002;169:5287-5293.
60. Pierce JW, Schoenleber R, Jesmok G, et al. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem. 1997;272:21096-21103.
61. Tsujimura T, Furitsu T, Morimoto M, et al. Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3. Int Arch Allergy Immunol. 1995;106:377-385.
62. Kitamura Y, Morii E, Jippo T. The c-kit receptor and the mi transcription factor: two important molecules for mast cell development. In: Razin E, Rivera J, eds. Signal Transduction in Mast Cells and Basophils. New York, NY: Springer-Verlag; 2003:31-38.
63. Wodnar-Filipowicz A, Moroni C. Regulation of interleukin 3 mRNA expression in mast cells occurs at the posttranscriptional level and is mediated by calcium ions. Proc Natl Acad Sci U S A. 1990;87:777-781.
64. Stassen M, Arnold M, Hultner L, et al. Murine bone marrow-derived mast cells as potent producers of IL-9: costimulatory function of IL-10 and kit ligand in the presence of IL-1. J Immunol. 2000;164:5549-5555.
65. Suzuki K, Nakajima H, Ikeda K, et al. IL-4-Stat6 signaling induces tristetraprolin expression and inhibits TNF-α production in mast cells. J Exp Med. 2003;198:1717-1727.
66. Prieschl EE, Gouilleux V, Walker C, Harrer NE, Baumruker T. A nuclear factor of activated T cell-like transcription factor in mast cells is involved in IL-5 gene regulation after IgE plus antigen stimulation. J Immunol. 1995;154:6112-6119.
67. Shuai K, Liu B. Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol. 2003;3:900-911.